Geron Corp (GERN) – 01-23-2009
An incoming liberal administration coupled with the general market rally made for a big run in stem cell companies recently. I don’t like GERN particularly, but it was the most interesting one on Friday so I picked it as the figurehead for this industry. Almost all pure stem cell stocks are below the minimum requirements of what you should be buying for real positions, but with research limitations already opening up quite a bit, undoubtedly there will be at least a few that break out for huge gains over the next 4 (or 8) years. With all the hype in these stocks going the opposite direction of the market, expect some huge profitable swings that you can play this year. Keep an eye on the top of the pack and get ready to pick some spots that suit your style.